KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.26 $4.27 Friday, 26th Apr 2024 GALT stock ended at $3.45. This is 1.43% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 7.83% from a day low at $3.45 to a day high of $3.72.
90 days $1.59 $4.27
52 weeks $1.28 $4.27

Historical Galectin Therapeutics Inc. prices

Date Open High Low Close Volume
Dec 08, 2020 $2.70 $2.74 $2.62 $2.67 325 555
Dec 07, 2020 $2.81 $2.88 $2.68 $2.75 246 776
Dec 04, 2020 $2.73 $2.82 $2.69 $2.81 140 338
Dec 03, 2020 $2.75 $2.87 $2.73 $2.74 452 488
Dec 02, 2020 $2.62 $2.85 $2.61 $2.75 344 475
Dec 01, 2020 $2.61 $2.70 $2.61 $2.64 143 021
Nov 30, 2020 $2.60 $2.65 $2.57 $2.60 142 668
Nov 27, 2020 $2.61 $2.69 $2.60 $2.65 90 021
Nov 25, 2020 $2.58 $2.70 $2.58 $2.61 95 753
Nov 24, 2020 $2.56 $2.67 $2.53 $2.62 153 030
Nov 23, 2020 $2.66 $2.66 $2.54 $2.55 198 622
Nov 20, 2020 $2.55 $2.66 $2.55 $2.64 99 368
Nov 19, 2020 $2.61 $2.66 $2.51 $2.58 172 583
Nov 18, 2020 $2.73 $2.77 $2.61 $2.61 190 776
Nov 17, 2020 $2.70 $2.78 $2.65 $2.73 107 876
Nov 16, 2020 $2.77 $2.84 $2.69 $2.73 163 709
Nov 13, 2020 $2.70 $2.80 $2.65 $2.75 162 235
Nov 12, 2020 $2.76 $2.85 $2.66 $2.70 191 709
Nov 11, 2020 $2.69 $2.81 $2.66 $2.80 219 707
Nov 10, 2020 $2.55 $2.72 $2.53 $2.69 252 843
Nov 09, 2020 $2.53 $2.76 $2.50 $2.52 245 667
Nov 06, 2020 $2.59 $2.62 $2.52 $2.58 87 285
Nov 05, 2020 $2.58 $2.63 $2.54 $2.59 99 314
Nov 04, 2020 $2.59 $2.71 $2.55 $2.60 85 414
Nov 03, 2020 $2.60 $2.65 $2.56 $2.60 103 127
Click to get the best stock tips daily for free!

About Galectin Therapeutics Inc.

Galectin Therapeutics. Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatiti... GALT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT